Physician
Sanjay Ghosh PHD MD PC
Sanjay Ghosh PHD MD PC was paid $254K by Medicaid between Jan 2018 and Sep 2022, across 17 billing codes. Its largest line is J0129, Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 74% of everything it billed.
33Billing provider infoSANJAY GHOSH PHD MD PC
WASHINGTON, MO 63090
WASHINGTON, MO 63090
33aNPI1992868277assigned 12/18/2006
33bProvider typeInternal Medicine Physician
28Total paid$254K
24GClaims4,832
24DCodes billed17
24AFirst – last monthJan 2018 – Sep 2022
Compared with peers
Next to other Internal Medicine Physician providers in Missouri
Rank by total paid#42 of 364
Median peer was paid$10K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,199 | $27K | |
| 2019 | 892 | $23K | |
| 2020 | 884 | $30K | |
| 2021 | 1,450 | $144K | |
| 2022 | 407 | $30K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 74% | 274 | 231 | $187K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 1,529 | 1,435 | $35K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.3% | 554 | 529 | $24K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 281 | 247 | $3K |
| 85651 | <1% | 1,101 | 1,066 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 14 | 14 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 14 | 14 | $799.94 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | 14 | $176.09 |
| 80305 | <1% | 26 | 26 | $137.38 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 291 | 253 | $45.20 |
| 36415 | Collection of venous blood by venipuncture | <1% | 504 | 479 | $14.76 |
| G9359 | Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier | 0% | 24 | 21 | $0.00 |
5 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGHOSH, SANJAY (PHD MD PC)